Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ribavirin Strategies for Chronic and Severe Acute Hepatitis E
NCT02558114Phase 4Terminated
- Sponsor
- Vall d'Hebron Research Institute
- Start
- Dec 2015
- Primary completion
- Nov 2018
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of ribavirin in hepatitis E (HEV), sponsored by Vall d'Hebron Research Institute. Started Dec 2015; status: terminated.
02
Drugs
ribavirin
03
Conditions
hepatitis E (HEV)
Beyond the preview
Go deeper on NCT02558114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02558114.